4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-22-060090
General Counsel and Secretary gave up 3,234 shares (to pay taxes)
- General Counsel and Secretary acquired 6,667 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2022-12-03 | Option exercise | +6,667 | 53,425 | D | ||
| KASINGER JAMES R. General Counsel and Secretary | 2022-12-05 | Shares withheld for taxes | −3,234 | $52.26 | $169,009 | 50,191 | D |
| Derivatives | |||||||
| KASINGER JAMES R. General Counsel and Secretary | 2022-12-03 | Option exercise · Restricted Stock Units | −6,667 | 0 | D | ||
Loading xslF345X03/doc4.xml…